title: [Comorbid autoimmune pathology in patients treated with disease modifying drugs].
abstract: Because of intensive growth of the prevalence of multiple sclerosis (MS) and other autoimmune diseases (AID) during the last years, the comorbidity of MS and AID is not a rarity. In this literature review, the development of comorbid AID in patients with MS is considered to be the probable complication of disease modifying therapy with drugs of different groups. The authors present the own data on the prevalence of comorbid autoimmune pathology in patients with MS treated with disease modifying drugs.
authors.affiliation: Rostov State Medical University, Rostov-on-Don, Russia.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Goncharova
authors.affiliation: The Research Institute of Clinical Immunology of Rostov State Medical University, Rostov-on-Don, Russia.
authors.forename: L P
authors.initials: LP
authors.lastname: Sizyakina
authors.affiliation: The Research Institute of Clinical Immunology of Rostov State Medical University, Rostov-on-Don, Russia.
authors.forename: R A
authors.initials: RA
authors.lastname: Belovolova
authors.affiliation: Rostov State Medical University, Rostov-on-Don, Russia.
authors.forename: V A
authors.initials: VA
authors.lastname: Megeryan
mesh_terms: D001327:Autoimmune Diseases / Q000139:chemically induced*; D015897:Comorbidity; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D015995:Prevalence
chemical_list: D007155:Immunologic Factors